Company Filing History:

21 out of 1,454

Sanofi

Years Active: 1993-2013

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8420679 - Aminothiazole derivatives and their use as CRF receptor ligands (2013-04-16),

2. 6806282 - Branched substituted amino derivatives of 3-amino-1-phenyl-1h-[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them (2004-10-19),

3. 6586456 - Aminothiazole derivatives and their use as CRF receptor ligands (2003-07-01),

4. 6344470 - Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same (2002-02-05),

5. RE37094 - Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them (2001-03-13),

6. 6172239 - Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors, their preparation and pharamaceutical compositions containing them (2001-01-09),

7. 5965579 - Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin (1999-10-12),

8. 5939449 - Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin (1999-08-17),

9. 5936123 - Hydrazine derivative compounds as intermediates for preparing (1999-08-10),

10. 5925661 - Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin (1999-07-20),

11. 5880135 - Substituted 4-phenylaminothiazoles, their process of preparation and the (1999-03-09),

12. 5744493 - 3-amidopyrazole derivatives and pharmaceutical compositions containing (1998-04-28),

13. 5744491 - 3-amidopyrazole derivatives, process for preparing these and (1998-04-28),

14. 5731340 - Glycinamide derivatives, processes for their preparation and medicines (1998-03-24),

15. 5723483 - Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin (1998-03-03),

Title: Innovative Contributions of Danielle Gully

Introduction

Danielle Gully, located in Saubens, France, is a prominent inventor in the field of pharmaceutical sciences. With an impressive portfolio of 28 patents, Gully has made significant strides in developing innovative compounds aimed at addressing critical health issues.

Latest Patents

Among his latest inventions are key patents that focus on aminothiazole derivatives. Specifically, one patent highlights the use of substituted 4-phenyl-2-aminothiazole derivatives as corticotrophin releasing factor (CRF) antagonists. Another notable patent involves branched substituted amino derivatives of 3-amino-1-phenyl-1H-[1,2,4]triazole, detailing methods for their production and their applications in pharmaceutical compositions emphasizing their therapeutic potential.

Career Highlights

Danielle Gully's career features significant associations with notable companies such as Sanofi and Elf Sanofi. His roles in these organizations have facilitated the development of groundbreaking innovations in the pharmaceutical industry. Gully's focus on creating effective medical compounds underscores his commitment to enhancing healthcare solutions.

Collaborations

Throughout his career, Gully has collaborated with esteemed colleagues, including Robert Boigegrain and Jean-Charles Molimard. These partnerships have not only enriched his work but have also contributed to the pool of knowledge in the fields of drug development and pharmaceutical research.

Conclusion

Danielle Gully stands out as an influential figure in pharmaceutical innovation, with his extensive patent portfolio and collaborations helping to pave the way for advancements in medical science. His work, characterized by a deep understanding of chemical compounds and their applications, continues to impact the health sector positively.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com